[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_7942 

# __Medical research and development__

## Risks linked to this technology

* [Absence of specific treatment or vaccine for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6538.md)
* [Lack of cure or vaccine for tuberculosis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7746.md)
* [Lack of effective treatment for baylisascariasis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7766.md)
* [Lack of effective treatment for newly emerging infectious diseases such as covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8113.md)
* [Socio-economic, demographic, and cultural factors contributing to the emergence and spread of disease.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9110.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_7.md)

## This technology is mentioned by

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_462.md)
* [Davis_epidemics_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)
* [Elrayies_prophylactic_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_451.md)
* [Guo_aerosol_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_477.md)

